These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The solitary hand lesion: bone scintigraphy of monostotic fibrous dysplasia. Novetsky GJ; Berlin L Clin Nucl Med; 1984 Oct; 9(10):590. PubMed ID: 6237822 [No Abstract] [Full Text] [Related]
4. Radionuclide bone imaging as an aid in the diagnosis of fibrous dysplasia: report of case. Shuster HL; Sadowsky D; Friedman JM J Oral Surg; 1979 Apr; 37(4):267-70. PubMed ID: 285232 [No Abstract] [Full Text] [Related]
5. Fibrous dysplasia associated with primary hyperparathyroidism in the absence of the McCune-Albright syndrome: Tc-99m MIBI and Tc-99m MDP findings. Kim SJ; Seok JW; Kim IJ; Kim YK; Jung DS; Kim DS Clin Nucl Med; 2003 May; 28(5):416-8. PubMed ID: 12702945 [No Abstract] [Full Text] [Related]
6. The role of bone scan in the diagnosis of Jaffé-Lichtenstein-Uehlinger syndrome. Chroustova D; Votruba M; Sprindrich J; Sosna B Nucl Med Rev Cent East Eur; 2004; 7(1):87-9. PubMed ID: 15318318 [TBL] [Abstract][Full Text] [Related]
7. Criteria and quantification of fibrous dysplasia on MDP scanning. Sathekge MM; Clauss RP Nuklearmedizin; 1995 Dec; 34(6):229-31. PubMed ID: 8596739 [TBL] [Abstract][Full Text] [Related]
8. Value of bone scan in the McCune-Albright syndrome. Report of a case. Edeburn GF; Mortensson W Acta Radiol Diagn (Stockh); 1986; 27(6):719-21. PubMed ID: 3812022 [TBL] [Abstract][Full Text] [Related]
9. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)]. Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900 [No Abstract] [Full Text] [Related]
11. Normal technetium-99m-MDP uptake in fibrous dysplasia of the hip. Sood A; Raman R; Jhobta A; Dhiman DS; Seam RK Hell J Nucl Med; 2009; 12(1):72-3. PubMed ID: 19330193 [No Abstract] [Full Text] [Related]
12. [Abnormal accumulation of 99mTc-phosphorous compounds in the breast]. Inoue Y; Shichijo S Rinsho Hoshasen; 1983 Aug; 28(8):845-9. PubMed ID: 6317921 [No Abstract] [Full Text] [Related]
13. [Early diagnosis of bone infarction in children with sickle cell anemia by MDP 99m Tc scanning]. Koren A; Fedchteyn S; Katsuni E Harefuah; 1982 Mar; 102(5):182-5. PubMed ID: 6214460 [No Abstract] [Full Text] [Related]
14. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications. Tan KF; Chang CH Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712 [No Abstract] [Full Text] [Related]
15. [Extraosseous accumulation of 99m-Tc-MDP--with special reference to intratumor accumulation]. Yasuda E; Yoshida H; Ichikawa H; Matsuo S; Kimura T; Kanamori I; Nakano S; Watahiki H; Takeda I Rinsho Hoshasen; 1983 Aug; 28(8):851-7. PubMed ID: 6228679 [No Abstract] [Full Text] [Related]
16. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios. Buell U; Kirsch CM; Kleinhans E; Jäger B J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711 [No Abstract] [Full Text] [Related]
17. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent]. Ishine M; Kawamura M; Koizumi M; Itoh H; Murase K; Inatsuki S; Iio A; Hamamoto K Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):389-97. PubMed ID: 6214765 [No Abstract] [Full Text] [Related]
18. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer. Pauwels EK; Heslinga JM; Zwaveling A Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915 [No Abstract] [Full Text] [Related]
19. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)]. Ishii C; Mori Y; Hata Y; Katsuyama N; Fujioka M; Fukazawa W; Hashimoto H; Horiuchi T; Fujioka M; Kawakami K Radioisotopes; 1981 Jul; 30(7):401-3. PubMed ID: 7323328 [No Abstract] [Full Text] [Related]